176 related articles for article (PubMed ID: 24048691)
1. Selective induction of P2Y14 receptor by RANKL promotes osteoclast formation.
Lee SA; Park JH; Lee SY
Mol Cells; 2013 Sep; 36(3):273-7. PubMed ID: 24048691
[TBL] [Abstract][Full Text] [Related]
2. UDP-sugars activate P2Y
Abbas ZSB; Latif ML; Dovlatova N; Fox SC; Heptinstall S; Dunn WR; Ralevic V
Vascul Pharmacol; 2018 Apr; 103-105():36-46. PubMed ID: 29253618
[TBL] [Abstract][Full Text] [Related]
3. Functional expression of the P2Y14 receptor in human neutrophils.
Scrivens M; Dickenson JM
Eur J Pharmacol; 2006 Aug; 543(1-3):166-73. PubMed ID: 16820147
[TBL] [Abstract][Full Text] [Related]
4. Identification of a carbohydrate recognition motif of purinergic receptors.
Zhao L; Wei F; He X; Dai A; Yang D; Jiang H; Wen L; Cheng X
Elife; 2023 Nov; 12():. PubMed ID: 37955640
[TBL] [Abstract][Full Text] [Related]
5. Functional expression of the P2Y14 receptor in murine T-lymphocytes.
Scrivens M; Dickenson JM
Br J Pharmacol; 2005 Oct; 146(3):435-44. PubMed ID: 15997228
[TBL] [Abstract][Full Text] [Related]
6. Role of UDP-Sugar Receptor P2Y
Mikolajewicz N; Komarova SV
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326617
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological effects mediated by UDP-glucose that are independent of P2Y14 receptor expression.
Scrivens M; Dickenson JM
Pharmacol Res; 2005 Jun; 51(6):533-8. PubMed ID: 15829433
[TBL] [Abstract][Full Text] [Related]
8. Novel vasocontractile role of the P2Y₁₄ receptor: characterization of its signalling in porcine isolated pancreatic arteries.
Alsaqati M; Latif ML; Chan SL; Ralevic V
Br J Pharmacol; 2014 Feb; 171(3):701-13. PubMed ID: 24138077
[TBL] [Abstract][Full Text] [Related]
9. The purinergic P2Y14 receptor links hepatocyte death to hepatic stellate cell activation and fibrogenesis in the liver.
Mederacke I; Filliol A; Affo S; Nair A; Hernandez C; Sun Q; Hamberger F; Brundu F; Chen Y; Ravichandra A; Huebener P; Anke H; Shi H; Martínez García de la Torre RA; Smith JR; Henderson NC; Vondran FWR; Rothlin CV; Baehre H; Tabas I; Sancho-Bru P; Schwabe RF
Sci Transl Med; 2022 Apr; 14(639):eabe5795. PubMed ID: 35385339
[TBL] [Abstract][Full Text] [Related]
10. Empowering human cardiac progenitor cells by P2Y
Khalafalla FG; Kayani W; Kassab A; Ilves K; Monsanto MM; Alvarez R; Chavarria M; Norman B; Dembitsky WP; Sussman MA
J Physiol; 2017 Dec; 595(23):7135-7148. PubMed ID: 28980705
[TBL] [Abstract][Full Text] [Related]
11. UDP-glucose, a cellular danger signal, and nucleotide receptor P2Y14 enhance the invasion of human extravillous trophoblast cells.
Katakura S; Takao T; Arase T; Yoshimasa Y; Tomisato S; Uchida S; Masuda H; Uchida H; Tanaka M; Maruyama T
Placenta; 2020 Nov; 101():194-203. PubMed ID: 33011563
[TBL] [Abstract][Full Text] [Related]
12. Gi-dependent cell signaling responses of the human P2Y14 receptor in model cell systems.
Fricks IP; Carter RL; Lazarowski ER; Harden TK
J Pharmacol Exp Ther; 2009 Jul; 330(1):162-8. PubMed ID: 19339661
[TBL] [Abstract][Full Text] [Related]
13. Geniposide attenuates inflammatory response by suppressing P2Y14 receptor and downstream ERK1/2 signaling pathway in oxygen and glucose deprivation-induced brain microvascular endothelial cells.
Li F; Li W; Li X; Li F; Zhang L; Wang B; Huang G; Guo X; Wan L; Liu Y; Zhang S; Kang S; Ma J
J Ethnopharmacol; 2016 Jun; 185():77-86. PubMed ID: 26976766
[TBL] [Abstract][Full Text] [Related]
14. Tools and drugs for uracil nucleotide-activated P2Y receptors.
Rafehi M; Müller CE
Pharmacol Ther; 2018 Oct; 190():24-80. PubMed ID: 29660366
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family.
Abbracchio MP; Boeynaems JM; Barnard EA; Boyer JL; Kennedy C; Miras-Portugal MT; King BF; Gachet C; Jacobson KA; Weisman GA; Burnstock G
Trends Pharmacol Sci; 2003 Feb; 24(2):52-5. PubMed ID: 12559763
[TBL] [Abstract][Full Text] [Related]
16. P2Y
Lin J; Liu F; Zhang YY; Song N; Liu MK; Fang XY; Liao DQ; Zhou C; Wang H; Shen JF
J Cell Physiol; 2019 Nov; 234(11):21199-21210. PubMed ID: 31032956
[TBL] [Abstract][Full Text] [Related]
17. UDP-glucose modulates gastric function through P2Y14 receptor-dependent and -independent mechanisms.
Bassil AK; Bourdu S; Townson KA; Wheeldon A; Jarvie EM; Zebda N; Abuin A; Grau E; Livi GP; Punter L; Latcham J; Grimes AM; Hurp DP; Downham KM; Sanger GJ; Winchester WJ; Morrison AD; Moore GB
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G923-30. PubMed ID: 19164486
[TBL] [Abstract][Full Text] [Related]
18. UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation.
Gao ZG; Ding Y; Jacobson KA
Biochem Pharmacol; 2010 Mar; 79(6):873-9. PubMed ID: 19896471
[TBL] [Abstract][Full Text] [Related]
19. SLAT negatively regulates RANKL-induced osteoclast differentiation.
Youn BU; Kim K; Kim JH; Lee J; Moon JB; Kim I; Park YW; Kim N
Mol Cells; 2013 Sep; 36(3):252-7. PubMed ID: 23996528
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel P2Y14 agonist and antagonist using conventional and nonconventional methods.
Hamel M; Henault M; Hyjazie H; Morin N; Bayly C; Skorey K; Therien AG; Mancini J; Brideau C; Kargman S
J Biomol Screen; 2011 Oct; 16(9):1098-105. PubMed ID: 21821827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
